Atlas Trials

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

Clinical trial NCT01394211 · TERMINATED

Trial details

NCT number
NCT01394211
Sponsor
University of Arizona
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast CancerRecurrent Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer
Start date
2011-07-13
Primary completion
2012-04-12
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.